4-Chloro-N-methylpyridine-2-carboxamide , 97% , 220000-87-3
CAS NO.:220000-87-3
Empirical Formula: C7H7ClN2O
Molecular Weight: 170.6
MDL number: MFCD02185921
EINECS: 606-888-1
| Pack Size | Price | Stock | Quantity |
| 1G | RMB23.20 | In Stock |
|
| 5G | RMB52.80 | In Stock |
|
| 25G | RMB158.40 | In Stock |
|
| others | Enquire |
PRODUCT Properties
| Melting point: | 41-43°C |
| Boiling point: | 317.8±27.0 °C(Predicted) |
| Density | 1.264±0.06 g/cm3(Predicted) |
| storage temp. | Keep in dark place,Sealed in dry,Room Temperature |
| solubility | Chloroform (Slightly), Dichloromethane (Slightly), Ethyl Acetate (Slightly), Met |
| form | Solid |
| pka | 13.41±0.46(Predicted) |
| color | Off-White to Light Yellow |
| InChI | InChI=1S/C7H7ClN2O/c1-9-7(11)6-4-5(8)2-3-10-6/h2-4H,1H3,(H,9,11) |
| InChIKey | BGVBBMZMEKXUTR-UHFFFAOYSA-N |
| SMILES | C1(C(NC)=O)=NC=CC(Cl)=C1 |
| CAS DataBase Reference | 220000-87-3(CAS DataBase Reference) |
Description and Uses
4-Chloro-N-methylpicolinamide is a polar organic compound that interacts with hydrogen bonds. It has been shown to inhibit the value-added of cancer cells by inhibiting protein synthesis to inhibit the growth of human hepatocellular carcinoma cells, bcr/abl kinase, and hct116 cells, and is a candidate for cancer treatment. Studies have shown that it also inhibits the proliferation of MDA-MB231 breast cancer cells by blocking growth factor activity. In addition, 4-Chloro-N-methylpicolinamide is a pharmaceutical intermediate component used in the preparation of the antineoplastic drugs regorafenib and sorafenib.
4-Chloro-N-methylpyridine-2-carboxamide (>90%) (cas# 220000-87-3) is a compound useful in organic synthesis.
Safety
| Symbol(GHS) | ![]() GHS07 |
| Signal word | Warning |
| Hazard statements | H315-H319-H335 |
| Precautionary statements | P261-P280a-P304+P340-P305+P351+P338-P405-P501a |
| Hazard Codes | Xn |
| Risk Statements | 22-36 |
| Safety Statements | 26 |
| HS Code | 2933399990 |







